Eton Pharmaceuticals (ETON) News Today $19.66 -0.62 (-3.06%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$19.34 -0.32 (-1.60%) As of 10/10/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ETON Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Eton Pharmaceuticals (NASDAQ:ETON) Upgraded to Hold at Zacks ResearchOctober 10 at 10:26 AM | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from BrokeragesOctober 10 at 8:53 AM | marketbeat.comWeiss Ratings Reaffirms "Sell (D-)" Rating for Eton Pharmaceuticals (NASDAQ:ETON)October 9, 2025 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Stock Price Down 5.4% - Should You Sell?October 1, 2025 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High on Analyst UpgradeSeptember 29, 2025 | marketbeat.comEton Pharmaceuticals (NASDAQ:ETON) Upgraded to Buy at Wall Street ZenSeptember 26, 2025 | marketbeat.comTop Growth Companies With Strong Insider OwnershipSeptember 24, 2025 | finance.yahoo.comEton Pharmaceuticals (NASDAQ:ETON) Trading 9.1% Higher - Here's WhySeptember 23, 2025 | marketbeat.comImplied Volatility Surging for Eton Pharmaceuticals Stock OptionsSeptember 22, 2025 | msn.comWe Might See A Profit From Eton Pharmaceuticals, Inc. (NASDAQ:ETON) SoonSeptember 22, 2025 | finance.yahoo.comEton Pharmaceuticals management to meet virtually with Craig-HallumSeptember 17, 2025 | msn.comAcadian Asset Management LLC Increases Stock Position in Eton Pharmaceuticals, Inc. $ETONSeptember 15, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Invests $704,000 in Eton Pharmaceuticals, Inc. $ETONSeptember 15, 2025 | marketbeat.comCubist Systematic Strategies LLC Purchases 59,961 Shares of Eton Pharmaceuticals, Inc. $ETONSeptember 9, 2025 | marketbeat.comPDT Partners LLC Makes New $334,000 Investment in Eton Pharmaceuticals, Inc. $ETONSeptember 7, 2025 | marketbeat.comNantahala Capital Management LLC Purchases 57,468 Shares of Eton Pharmaceuticals, Inc. $ETONSeptember 3, 2025 | marketbeat.comState of Wyoming Invests $343,000 in Eton Pharmaceuticals, Inc. $ETONSeptember 3, 2025 | marketbeat.comWellington Management Group LLP Invests $328,000 in Eton Pharmaceuticals, Inc. $ETONSeptember 3, 2025 | marketbeat.comEton Pharmaceuticals, Inc. $ETON Shares Sold by Mink Brook Asset Management LLCAugust 26, 2025 | marketbeat.comInsider Selling: Eton Pharmaceuticals (NASDAQ:ETON) CFO Sells 2,631 Shares of StockAugust 21, 2025 | insidertrades.comEton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare ConferenceAugust 20, 2025 | globenewswire.comCraig-Hallum Sticks to Its Buy Rating for Eton Pharmaceuticals (ETON)August 17, 2025 | theglobeandmail.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Bought by Connor Clark & Lunn Investment Management Ltd.August 15, 2025 | marketbeat.comEton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Sold by Informed Momentum Co LLCAugust 14, 2025 | marketbeat.comEton Pharmaceuticals Reports Strong Q2 Growth Amid ChallengesAugust 13, 2025 | msn.comWall Street Zen Downgrades Eton Pharmaceuticals (NASDAQ:ETON) to HoldAugust 10, 2025 | marketbeat.comEton targets $80M revenue run-rate in Q3 2025 as product launches accelerateAugust 8, 2025 | msn.comEton Pharmaceuticals, Inc. (ETON) Q2 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comEton Pharmaceuticals: Growth At A Reasonable Price, Or Maybe Even Better With OptionsAugust 8, 2025 | seekingalpha.comEton Pharmaceuticals Reports Second Quarter 2025 Financial ResultsAugust 7, 2025 | globenewswire.comEton Pharmaceuticals (ETON) to Release Quarterly Earnings on ThursdayAugust 1, 2025 | marketbeat.comNeurocrine Biosciences Positioned For Growth And New Potential BlockbustersJuly 31, 2025 | seekingalpha.comEton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025July 28, 2025 | globenewswire.comB. Riley Analysts Lift Earnings Estimates for ETONJuly 21, 2025 | marketbeat.comB. Riley Research Analysts Raise Earnings Estimates for ETONJuly 18, 2025 | marketbeat.comAdrenal Crisis Market Analysis and Forecast Report 2025-2035 with Competitive Benchmarking of Eton Pharmaceuticals, Antares Pharma, and PfizerJuly 11, 2025 | finance.yahoo.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - Seeking AlphaJuly 9, 2025 | seekingalpha.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution) - MorningstarJuly 9, 2025 | morningstar.comMEton Pharmaceuticals Announces FDA Acceptance of NDA for ET-600 with Target Action Date of February 25, 2026 - NasdaqJuly 9, 2025 | nasdaq.comEton Pharmaceuticals Inc Sustainability - MorningstarJuly 9, 2025 | morningstar.comMEton Pharmaceuticals Shares Rise Premarket as FDA to Review ET-600July 8, 2025 | marketwatch.comEton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)July 8, 2025 | globenewswire.comEton Pharmaceuticals Inc. Annual Income Statement - MarketWatchJuly 2, 2025 | marketwatch.comWestside Investment Management Inc. Sells 81,572 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON)June 30, 2025 | marketbeat.comEton Pharmaceuticals to join Russell indexesJune 27, 2025 | msn.comEton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesJune 27, 2025 | finance.yahoo.comEton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesJune 27, 2025 | globenewswire.comEton Pharmaceuticals IncJune 20, 2025 | morningstar.comMInsiders Back These 3 High Growth CompaniesJune 17, 2025 | finance.yahoo.comDavid Krempa Sells 6,800 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) StockJune 17, 2025 | insidertrades.com Get Eton Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ETON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ETON Media Mentions By Week ETON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETON News Sentiment▼1.090.77▲Average Medical News Sentiment ETON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETON Articles This Week▼64▲ETON Articles Average Week Get the Latest News and Ratings for ETON and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Eton Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies OCUL News ANIP News VERA News TWST News DYN News APGE News COGT News TLRY News ABCL News IMCR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ETON) was last updated on 10/13/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eton Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eton Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
